Coronavirus Notebook: Oxford/AZ Vaccine Nears UK Approval; Argentina OKs Russia's Sputnik V
Executive Summary
The latest round-up from the Pink Sheet of developments relating to COVID-19.
You may also be interested in...
Finance Watch: Venture Capital On Track For Another Record Year
Private Company Edition: With $8.9bn raised in the second quarter, venture capital investment in biopharma companies reached its second highest quarterly total to date – behind only Q1 of this year. Also, Nimbus Therapeutics raised $105m and European drug developers get in on the VC action.
Argentina Follows UK In Backing Oxford/AstraZeneca COVID-19 Vaccine
While the US and EU regulators seem less than keen on the data package offered to date on COVID-19 Vaccine AstraZeneca, Latin American countries are moving quickly to follow the UK in backing the cost-effective and more-easily deliverable option.
After UK OK, Argentina Backs AstraZeneca/Oxford COVID-19 Vaccine
While the US and EU regulators seem less than keen on the data package offered to date on COVID-19 Vaccine AstraZeneca, Latin American countries are moving quickly to follow the UK in backing the cost-effective option.